Benicar hct and Ocular hyperaemia - a phase IV clinical study of FDA data

Summary:

Ocular hyperaemia is reported as a side effect among people who take Benicar hct (hydrochlorothiazide; olmesartan medoxomil), especially for people who are female, 60+ old, also take Nexium, and have Pain in jaw.

The phase IV clinical study analyzes which people have Ocular hyperaemia when taking Benicar hct. It is created by eHealthMe based on reports of 10,269 people who have side effects when taking Benicar hct from the FDA, and is updated regularly.

What is Benicar hct?

Benicar hct has active ingredients of hydrochlorothiazide; olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 10,919 Benicar hct users. Check the latest studies of Benicar hct.

What is Ocular hyperaemia?

Ocular hyperaemia (an abnormally large amount of blood in eye) is found to be associated with 1,356 drugs and 1,499 conditions by eHealthMe. Check the latest studies of Ocular hyperaemia.

On Jul, 23, 2026

10,269 people reported to have side effects when taking Benicar hct.
Among them, 12 people (0.12%) have Ocular hyperaemia.

Could Benicar hct cause Ocular hyperaemia?

Among these 12 people:

What is the gender of people who have Ocular hyperaemia when taking Benicar hct? *

female: 58.33 %
male: 41.67 %

What is the age of people who have Ocular hyperaemia when taking Benicar hct? *

What are other drugs people take besides Benicar hct? *

What are other side effects people have besides Ocular hyperaemia? *

Dry Eyes (lack of adequate tears): 7 people, 58.33%
Intervertebral Disc Degeneration (spinal disc degeneration): 6 people, 50.00%
Urinary Tract Infection: 5 people, 41.67%
Injury: 5 people, 41.67%
Pneumonia: 5 people, 41.67%
Hair Loss: 5 people, 41.67%
Depression: 5 people, 41.67%
Stress And Anxiety: 5 people, 41.67%
Neuropathy Peripheral (surface nerve damage): 5 people, 41.67%
Fainting (loss of consciousness and postural tone): 5 people, 41.67%

What are the existing conditions these people have? *

Weight Decreased: 4 people, 33.33%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 33.33%
Pain In Jaw: 4 people, 33.33%
Back Pain: 2 people, 16.67%
Intraocular Pressure Test Abnormal: 1 person, 8.33%
Bronchial Carcinoma (lung cancer): 1 person, 8.33%
Cystitis Interstitial (unknown cause characterized by bladder pain): 1 person, 8.33%
Gastric Disorder (disease of stomach): 1 person, 8.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 8.33%
Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Benicar hct and have Ocular hyperaemia?

- Check whether Ocular hyperaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Benicar hct:

Benicar hct (10,919 reports)

Ocular hyperaemia treatments and more:

Ocular hyperaemia (47,107 reports)

How severe was Ocular hyperaemia and when was it recovered:

Ocular hyperaemia in Benicar hct

Expand to all the drugs that have ingredients of hydrochlorothiazide; olmesartan medoxomil:

Ocular hyperaemia and drugs with ingredients of hydrochlorothiazide; olmesartan medoxomil

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Benicar hct:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ocular hyperaemia:

Ocular hyperaemia (1,356 drugs)

Browse all the conditions that are associated with Ocular hyperaemia:

Ocular hyperaemia (1,499 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydrochlorothiazide; olmesartan medoxomil (the active ingredients of Benicar hct) and Benicar hct (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.